FOXRED2 is a FAD-dependent oxidoreductase with emerging roles in cancer metabolism and disease pathogenesis. The protein likely functions as a flavoprotein capable of reductive activation of hypoxia-targeting prodrugs 1, demonstrating enzymatic activity toward xenobiotic metabolism previously uncharacterized for this protein. In melanoma, FOXRED2 expression is significantly elevated compared to normal skin, and knockdown inhibits proliferation, invasion, and migration while promoting apoptosis 2, suggesting oncogenic function in cutaneous malignancy. Beyond cancer, FOXRED2 has been identified through machine learning as a key gene associated with diabetic vascular aging and altered immune cell infiltration in vascular smooth muscle 3. Genetic variation in FOXRED2 (SNP rs144281) correlates with differential sensitivity to the anesthetic sevoflurane 4, indicating pharmacogenetic relevance. Additionally, FOXRED2 variants appear associated with COVID-19 severity outcomes 5 and malignant progression of neuroepithelial tumors 6. The gene is also part of a KRAS-driven transcriptomic signature with prognostic power in non-small cell lung cancer 7. These findings collectively suggest FOXRED2's multifaceted involvement in redox metabolism, cancer biology, vascular disease, and immune regulation, though its precise molecular mechanisms in most contexts remain incompletely characterized.